Jeffrey W. Burris - 03 Mar 2026 Form 4 Insider Report for Indivior Pharmaceuticals, Inc. (INDV)

Role: Chief Legal Officer
Signature: /s/Alice Givens, Power of Attorney
Issuer symbol: INDV
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 15:59:35 UTC
Previous filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Burris Jeffrey W	Chief Legal Officer	10710 MIDLOTHIAN TURNPIKE, SUITE 125, NORTH CHESTERFIELD	/s/Alice Givens, Power of Attorney	05 Mar 2026	0001484322

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INDV	Common Stock	Options Exercise		+79,893	+289%		107,550	03 Mar 2026	Direct	F1, F2
transaction	INDV	Common Stock	Tax liability		-36,032	-34%	$31.98^*	71,518	03 Mar 2026	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INDV	Performance Stock Units	Options Exercise		-104,300	-100%		0	03 Mar 2026	Common Stock	104,300	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 79,893 shares vested out of the 104.300 target amount.
F2	Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3	Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026.